Blog

C4IP Coalition Updates: January 2024

Happy New Year! C4IP’s 2024 has been off to a busy start. Here’s a roundup of what our Coalition has accomplished so far this year. On January 31, C4IP Co-Chair Andrei Iancu and former NSCAI Director of Research and Analysis Rama Elluru published an opinion essay in Reuters centered on the intersection of artificial intelligence

Read More »

This Month in IP: January 2024

Innovation requires IP. Without a strong patent system, innovation does not happen at scale. Virtually every invention of impact is patented, as exemplified by these historical examples from the month of January: 1967: On January 3, Harry Thomason received a patent for technology to heat and cool a building using solar energy. Thomason’s invention is

Read More »

Fact Check: Misusing the Bayh-Dole Act’s March-In Rights is Not an Effective Way to Reduce Drug Prices

Claim: On December 7, the Biden administration proposed a policy framework claiming a newfound authority, under the 43-year-old Bayh-Dole Act, to rescind patent licenses on drugs, energy, climate change, and all other inventions that benefit from federal research funding based on the price of the resulting product. The administration asserts that this framework is an

Read More »

New Op-Ed from C4IP Board: Europe Stands at a Crossroads on Technology Policy

Yesterday, the C4IP Board published an opinion piece in Euractiv highlighting how the European Commission’s recent proposal for standard-essential patents (SEPs) has empowered China to unilaterally set its own licensing terms, jeopardizing a longstanding model of international cooperation and threatening Europe’s own leadership in wireless technology. In the piece, the board explains how SEPs —

Read More »

Celebrating American Innovation: Ashok Gadgil

C4IP is highlighting the accomplishments of Ashok Gadgil from the University of California, Berkeley. His groundbreaking invention, utilizing ultraviolet light to purify water, was brought to market pursuant to the Bayh-Dole Act and has since saved millions of lives across the globe. Ashok Gadgil was born in Mumbai, India, in 1950. He attended the University

Read More »

New Op-Ed from C4IP Co-Chairs David Kappos and Andrei Iancu: President Biden’s domestic technology seizure plan

Over the weekend, C4IP Co-Chairs and former USPTO Directors David Kappos and Andrei Iancu published an opinion piece in The Hill detailing how the Biden administration’s new proposal for march-in rights under the Bayh-Dole Act would decimate innovation across numerous crucial technology sectors. The administration’s unprecedented proposal, announced in December, would allow government bureaucrats to

Read More »

New Op-Ed from Institute for Policy Innovation Resident Scholar Merrill Matthews: Blame Washington for Drug Shortages

Merrill Matthews, a resident scholar with the Institute for Policy Innovation, recently published an opinion piece in RealClearHealth calling attention to the numerous attacks on intellectual property that are exacerbating ongoing shortages of prescription medicines. More than 300 drugs are currently in shortage, including 15 cancer drugs, due to falling profit margins in the drug

Read More »

This Month in IP: The Impact of the Bayh-Dole Act

The Bayh-Dole Act revolutionized U.S. innovation by decentralizing the licensing process for federally funded research. By giving universities and other nonprofits the ability to license their researchers’ discoveries to the private sector, the Bayh-Dole Act incentivized them to turn their cutting-edge research into tangible products. The law’s impact has proven substantial, contributing nearly $2 trillion

Read More »

C4IP Coalition Updates: December 2023

Happy holidays! C4IP has been very productive this December. Here’s a roundup of what our Coalition accomplished to close out 2023. On December 20, C4IP published an issue brief on the Bayh-Dole Act and march-in rights following the Biden administration’s new – and unprecedented – proposal for government intervention in innovation and technology companies.  On December 14, C4IP

Read More »

Fact Check: The PREVAIL Act Would Not Protect “Bad” Patents

Claim: In November, senior policy analyst Joe Mullin of the Electronic Frontier Foundation (EFF) published an article claiming that the reforms included in the PREVAIL Act would unfairly protect the owners of “bad,” low-quality patents at the expense of small businesses and software developers. Correction: PREVAIL allows the challenger of a patent to decide where it wants its challenge

Read More »

Celebrating American Innovation: Lloyd Hall

C4IP is recognizing Lloyd Hall, whose invention of food preservatives helped to reduce global food spoilage and hunger. Born in Elgin, Illinois, in 1894, Lloyd Hall was a dedicated student. Hall earned a scholarship to Northwestern University and earned his Bachelor’s degree in pharmaceutical chemistry in 1916. He next attended graduate school at the University of Chicago. As

Read More »

New Op-Ed from C4IP Executive Director Frank Cullen: Innovators Need Patent Reform Now

Frank Cullen, C4IP’s executive director, recently published an opinion piece in InsideSources tracing back the origins of the legal confusion surrounding patent eligibility — and outlining how the Patent Eligibility Restoration Act would clarify patent eligibility in order to empower the researchers, scientists, and inventors who drive our innovation economy. Cullen’s piece details the numerous

Read More »

C4IP Coalition Updates: January 2024

Happy New Year! C4IP’s 2024 has been off to a busy start. Here’s a roundup of what our Coalition has accomplished so ...

This Month in IP: January 2024

Innovation requires IP. Without a strong patent system, innovation does not happen at scale. Virtually every invention of impact is patented, as ...

Fact Check: Misusing the Bayh-Dole Act’s March-In Rights is Not an Effective Way to Reduce Drug Prices

Claim: On December 7, the Biden administration proposed a policy framework claiming a newfound authority, under the 43-year-old Bayh-Dole Act, to rescind ...

New Op-Ed from C4IP Board: Europe Stands at a Crossroads on Technology Policy

Yesterday, the C4IP Board published an opinion piece in Euractiv highlighting how the European Commission’s recent proposal for standard-essential patents (SEPs) has ...

Celebrating American Innovation: Ashok Gadgil

C4IP is highlighting the accomplishments of Ashok Gadgil from the University of California, Berkeley. His groundbreaking invention, utilizing ultraviolet light to purify ...

New Op-Ed from C4IP Co-Chairs David Kappos and Andrei Iancu: President Biden’s domestic technology seizure plan

Over the weekend, C4IP Co-Chairs and former USPTO Directors David Kappos and Andrei Iancu published an opinion piece in The Hill detailing ...

New Op-Ed from Institute for Policy Innovation Resident Scholar Merrill Matthews: Blame Washington for Drug Shortages

Merrill Matthews, a resident scholar with the Institute for Policy Innovation, recently published an opinion piece in RealClearHealth calling attention to the ...

This Month in IP: The Impact of the Bayh-Dole Act

The Bayh-Dole Act revolutionized U.S. innovation by decentralizing the licensing process for federally funded research. By giving universities and other nonprofits the ...

C4IP Coalition Updates: December 2023

Happy holidays! C4IP has been very productive this December. Here’s a roundup of what our Coalition accomplished to close out 2023. On ...

Fact Check: The PREVAIL Act Would Not Protect “Bad” Patents

Claim: In November, senior policy analyst Joe Mullin of the Electronic Frontier Foundation (EFF) published an article claiming that the reforms included in the PREVAIL ...

Celebrating American Innovation: Lloyd Hall

C4IP is recognizing Lloyd Hall, whose invention of food preservatives helped to reduce global food spoilage and hunger. Born in Elgin, Illinois, in ...

New Op-Ed from C4IP Executive Director Frank Cullen: Innovators Need Patent Reform Now

Frank Cullen, C4IP’s executive director, recently published an opinion piece in InsideSources tracing back the origins of the legal confusion surrounding patent ...
Scroll to Top